Ignite Creation Date:
2025-12-24 @ 5:50 PM
Ignite Modification Date:
2026-01-23 @ 3:02 AM
Study NCT ID:
NCT06340568
Status:
RECRUITING
Last Update Posted:
2025-12-15
First Post:
2024-03-25
Is Gene Therapy:
True
Has Adverse Events:
False
Brief Title:
A Clinical Study of the Anti-cancer Effects of an Investigational Therapy or Chemotherapy in Patients With Recurring Uterine Cancer
Sponsor:
BioNTech SE
Organization:
Conditions & Keywords Data
Conditions:
Conditions
| Condition Brief | Condition Text | View |
|---|---|---|
| None | Endometrial Cancer | View |
Keywords:
Keywords
| Keyword Brief | Keyword Text | View |
|---|---|---|
| None | Human epidermal growth factor receptor 2 (HER2) | View |
| None | HER2-expressing tumors | View |
| None | Recurrent endometrial cancer | View |
| None | IHC scores 1+, 2+, and 3+ | View |
| None | Immune checkpoint inhibitor | View |
| None | Platinum-based therapy | View |
| None | HER2 protein expression | View |
| None | HER2-expressing endometrial cancer | View |
| None | ErbB-2 receptor | View |
| None | Antibody drug conjugate (ADC) | View |